German health minister hails success of DMPs (disease management programmes)
This article was originally published in Clinica
Executive Summary
Over one million people have signed up to Germany's disease management programmes (DMPs) since their inception in 2001. The programmes, the brainchild of health minister Ulla Schmidt, are aimed at providing optimum care to the chronically ill, whilst cutting health service costs. "Disease management programmes are a model of success, despite all the original opposition to them," Ms Schmidt said last week.
You may also be interested in...
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.
Roche Gets Adjuvant ALK+ Lung Cancer To Itself With Alecensa Approval
The US FDA cleared Roche’s supplemental approval request for ALK inhibitor Alecensa in ALK-positive non-small cell lung cancer following tumor resection.